Metastatic Pancreatic Cancer: ASCO Clinical Practice Guideline Update von Sohal, Davendra P S, Kennedy, Erin B, Khorana, Alok, Copur, Mehmet S, Crane, Christopher H, Garrido-Laguna, Ignacio, Krishnamurthi, Smitha, Moravek, Cassadie, O'Reilly, Eileen M, Philip, Philip A, Ramanathan, Ramesh K, Ruggiero, Joseph T, Shah, Manish A, Urba, Susan, Uronis, Hope E, Lau, Michelle W, Laheru, Daniel

Volltext

Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial von Von Hoff, Daniel D, Ramanathan, Ramesh K, Borad, Mitesh J, Laheru, Daniel A, Smith, Lon S, Wood, Tina E, Korn, Ronald L, Desai, Neil, Trieu, Vuong, Iglesias, Jose L, Zhang, Hui, Soon-Shiong, Patrick, Shi, Tao, Rajeshkumar, N V, Maitra, Anirban, Hidalgo, Manuel

Volltext

Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline von Sohal, Davendra P S, Mangu, Pamela B, Khorana, Alok A, Shah, Manish A, Philip, Philip A, O'Reilly, Eileen M, Uronis, Hope E, Ramanathan, Ramesh K, Crane, Christopher H, Engebretson, Anitra, Ruggiero, Joseph T, Copur, Mehmet S, Lau, Michelle, Urba, Susan, Laheru, Daniel

Volltext

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial von LOEHRER, Patrick J, YANG FENG, BENSON, Al B, CARDENES, Higinia, WAGNER, Lynne, BRELL, Joanna M, CELLA, David, FLYNN, Patrick, RAMANATHAN, Ramesh K, CRANE, Christopher H, ALBERTS, Steven R

Volltext

Safety and Efficacy of Oxaliplatin and Fluoropyrimidine Regimens With or Without Bevacizumab As First-Line Treatment of Metastatic Colorectal Cancer: Results of the TREE Study von HOCHSTER, Howard S, HART, Lowell L, SCHWARTZBERG, Lee, HEDRICK, Eric, RAMANATHAN, Ramesh K, CHILDS, Barrett H, HAINSWORTH, John D, COHN, Allen L, WONG, Lucas, FEHRENBACHER, Louis, ABUBAKR, Yousif, WASIF SAIF, M

Volltext

Genomic landscape of diploid and aneuploid microsatellite stable early onset colorectal cancer von Zhou, Yumei, Chen, Xianfeng, Chen, Jun, Kendrick, Conner D., Ramanathan, Ramesh K., Graham, Rondell P., Kossick, Kimberlee F., Boardman, Lisa A., Barrett, Michael T.

Volltext

Chemotherapy induced neutropenia at 1-month mark is a predictor of overall survival in patients receiving TAS-102 for refractory metastatic colorectal cancer: a cohort study von Kasi, Pashtoon M, Kotani, Daisuke, Cecchini, Michael, Shitara, Kohei, Ohtsu, Atsushi, Ramanathan, Ramesh K, Hochster, Howard S, Grothey, Axel, Yoshino, Takayuki

Volltext

Genomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer von Barrett, Michael T, Anderson, Karen S, Lenkiewicz, Elizabeth, Andreozzi, Mariacarla, Cunliffe, Heather E, Klassen, Christine L, Dueck, Amylou C, McCullough, Ann E, Reddy, Srikanth K, Ramanathan, Ramesh K, Northfelt, Donald W, Pockaj, Barbara A

Volltext

Multicenter Phase II Study of Irinotecan, Cisplatin, and Bevacizumab in Patients With Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma von SHAH, Manish A, RAMANATHAN, Ramesh K, SCHWARTZ, Gary K, KELSEN, David P, ILSON, David H, LEVNOR, Alissa, D'ADAMO, David, O'REILLY, Eileen, TSE, Archie, TROCOLA, Robin, SCHWARTZ, Lawrence, CAPANU, Marinela

Volltext

Pharmacogenetic Predictors of Adverse Events and Response to Chemotherapy in Metastatic Colorectal Cancer: Results From North American Gastrointestinal Intergroup Trial N9741 von MCLEOD, Howard L, SARGENT, Daniel J, GROTHEY, Axel, MORTON, Roscoe F, GOLDBERG, Richard M, MARSH, Sharon, GREEN, Erin M, KING, Cristi R, FUCHS, Charles S, RAMANATHAN, Ramesh K, WILLIAMSON, Stephen K, FINDLAY, Brian P, THIBODEAU, Stephen N

Volltext

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer von GOLDBERG, Richard M, SARGENT, Daniel J, MORTON, Roscoe F, FUCHS, Charles S, RAMANATHAN, Ramesh K, WILLIAMSON, Stephen K, FINDLAY, Brian P, PITOT, Henry C, ALBERTS, Steven R

Volltext

Immunotherapy in pancreatic cancer treatment: a new frontier von Thind, Komal, Padrnos, Leslie J., Ramanathan, Ramesh K., Borad, Mitesh J.

Volltext

Oxaliplatin Combined With Weekly Bolus Fluorouracil and Leucovorin As Surgical Adjuvant Chemotherapy for Stage II and III Colon Cancer: Results From NSABP C-07 von KUEBLER, J. Philip, WIEAND, H. Samuel, ZAPAS, John L, GOODWIN, J. Wendall, FEHRENBACHER, Louis, RAMANATHAN, Ramesh K, CONLEY, Barbara A, FLYNN, Patrick J, SOORI, Gamini, COLMAN, Lauren K, LEVINE, Edward A, LANIER, Keith S, OCONNELL, Michael J, WOLMARK, Norman, SMITH, Roy E, COLANGELO, Linda H, YOTHERS, Greg, PETRELLI, Nicholas J, FINDLAY, Michael P, SEAY, Thomas E, ATKINS, James N

Volltext

Five-Year Data and Prognostic Factor Analysis of Oxaliplatin and Irinotecan Combinations for Advanced Colorectal Cancer: N9741 von SANOFF, Hanna K, SARGENT, Daniel J, CAMPBELL, Megan E, MORTON, Roscoe F, FUCHS, Charles S, RAMANATHAN, Ramesh K, WILLIAMSON, Stephen K, FINDLAY, Brian P, PITOT, Henry C, GOLDBERG, Richard M

Volltext

Integrated genomic and epigenomic analysis of breast cancer brain metastasis von Salhia, Bodour, Kiefer, Jeff, Ross, Julianna T D, Metapally, Raghu, Martinez, Rae Anne, Johnson, Kyle N, DiPerna, Danielle M, Paquette, Kimberly M, Jung, Sungwon, Nasser, Sara, Wallstrom, Garrick, Tembe, Waibhav, Baker, Angela, Carpten, John, Resau, Jim, Ryken, Timothy, Sibenaller, Zita, Petricoin, Emanuel F, Liotta, Lance A, Ramanathan, Ramesh K, Berens, Michael E, Tran, Nhan L

Volltext

Response-Independent Survival Benefit in Metastatic Colorectal Cancer: A Comparative Analysis of N9741 and AVF2107 von GROTHEY, Axel, HEDRICK, Eric E, MASS, Robert D, SARKAR, Somnath, SUZUKI, Sam, RAMANATHAN, Ramesh K, HURWITZ, Herbert I, GOLDBERG, Richard M, SARGENT, Daniel J

Volltext

Clinical study of genomic drivers in pancreatic ductal adenocarcinoma von Barrett, Michael T, Deiotte, Ray, Lenkiewicz, Elizabeth, Malasi, Smriti, Holley, Tara, Evers, Lisa, Posner, Richard G, Jones, Timothy, Han, Haiyong, Sausen, Mark, Velculescu, Victor E, Drebin, Jeffrey, O'Dwyer, Peter, Jameson, Gayle, Ramanathan, Ramesh K, Von Hoff, Daniel D

Volltext

A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer von Ramanathan, Ramesh K., Thomas, Gary W., Khorana, Alok A., Shah, Satish, Zhou, Cathy, Wong, Sofia, Cole Jr, George, James, Danelle, Gabrail, Nashat Y.

Volltext

Randomized Controlled Trial of Reduced-Dose Bolus Fluorouracil Plus Leucovorin and Irinotecan or Infused Fluorouracil Plus Leucovorin and Oxaliplatin in Patients With Previously Un... von MEROPOL, Neal J, GOLDBERG, Richard M, SARGENT, Daniel J, MORTON, Roscoe F, FUCHS, Charles S, RAMANATHAN, Ramesh K, WILLIAMSON, Stephen K, FINDLAY, Brian P, PITOT, Henry C, ALBERTS, Steven

Volltext

Superiority of Oxaliplatin and Fluorouracil-Leucovorin Compared With Either Therapy Alone in Patients With Progressive Colorectal Cancer After Irinotecan and Fluorouracil-Leucovori... von ROTHENBERG, Mace L, OZA, Amit M, LE BAIL, Nathalie, HALLER, Daniel G, BIGELOW, Robert H, BERLIN, Jordan D, MARSHALL, John L, RAMANATHAN, Ramesh K, HART, Lowell L, GUPTA, Sunil, GARAY, Carlos A, BURGER, Brent G

Volltext